Hod Hasharon, Israel

Shira Cohen

USPTO Granted Patents = 5 

 

 

Average Co-Inventor Count = 2.2

ph-index = 1

Forward Citations = 9(Granted Patents)


Location History:

  • Herzliya, IL (2014 - 2016)
  • Hod Hasharon, IL (2020 - 2022)

Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Shira Cohen: Innovator in Fat Loss and Liver Treatment

Introduction

Shira Cohen, based in Hod Hasharon, Israel, is a prominent inventor in the field of biopharma. With a total of five patents to his name, Cohen has made significant contributions to the development of pharmaceutical compounds aimed at addressing obesity and liver-related conditions.

Latest Patents

Cohen's latest innovations include two impactful patents. The first is an A3 adenosine receptor (AAR) ligand designed to enhance fat loss effects, including weight reduction, body fat mass reduction, obesity treatment, and inhibiting adipocyte proliferation. This patent includes comprehensive details on relevant pharmaceutical compositions and methods for effective treatment.

The second patent involves a method utilizing the AAR ligand, specifically Cl-IB-MECA, for treating fibrotic liver tissue. This invention is particularly significant for its potential to reduce ectopic fat accumulation in conditions like non-alcoholic fatty liver disease (NAFLD). It details the preparation of pharmaceutical compositions and methods associated with this ligand, demonstrating Cohen's commitment to tackling metabolic disorders.

Career Highlights

Cohen currently works at Can-Fite Biopharma Ltd., a leader in developing innovative therapeutic solutions. Throughout his career, he has focused on ground-breaking research that seeks to improve treatments for obesity and liver diseases, making a notable impact in the biopharmaceutical field.

Collaborations

Shira Cohen collaborates with talented individuals such as Pnina Fishman and Motti Farbstein. Their collective expertise contributes to the advancement of Can-Fite's objectives and enhances the development of novel therapies aimed at improving patient outcomes.

Conclusion

Shira Cohen stands out as an inventor dedicated to advancing treatments for obesity and liver diseases. With his innovative patents and collaborative efforts at Can-Fite Biopharma Ltd., Cohen continues to shape the future of biopharmaceutical solutions, demonstrating the vital role of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…